Target Interacting Protein Information
Target General Information | Top | ||||
---|---|---|---|---|---|
Target ID | T89361 | Target Info | |||
Target Name | Cyclin-dependent kinase 6 (CDK6) | ||||
Synonyms | Serine/threonine-protein kinase PLSTIRE; Serine/threonine protein kinase PLSTIRE; Cell division protein kinase 6; CDKN6 | ||||
Target Type | Successful Target | ||||
Gene Name | CDK6 | ||||
Biochemical Class | Kinase | ||||
UniProt ID |
Target Interacting Proteins | Top | ||||
---|---|---|---|---|---|
Cell cycle related proteins | [+] 7 Cell cycle related proteins | + | |||
Interacting Target Name | Multiple tumor suppressor 1 (CDKN2A) | Literature-reported Target | Interacting Protein Info | ||
UniProt ID | |||||
Synonyms | Tumour suppressor gene p16; P16-INK4a; p16INK4A; P16-INK4; P16 gene; MTS-1; Cyclin-dependent kinase inhibitor 2A; Cyclin-dependent kinase 4 inhibitor A; CDK4I | ||||
Evidence Score (E-score) | 9 Experimental Evidences | + | |||
1 | Affinity Capture-MS | [1] | |||
2 | Affinity Capture-MS | [2] | |||
3 | Affinity Capture-MS | [3] | |||
4 | Affinity Capture-Western | [4] | |||
5 | Biochemical Activity | [5] | |||
6 | Co-crystal Structure | [6] | |||
7 | Fluorescence Resonance Energy Transfer | [7] | |||
8 | Protein-peptide | [8] | |||
9 | Reconstituted Complex | [9] | |||
Interacting Target Name | Cyclin D (CCND3) | Literature-reported Target | Interacting Protein Info | ||
UniProt ID | |||||
Synonyms | G1/S-specific cyclin-D3 | ||||
Evidence Score (E-score) | 8 Experimental Evidences | + | |||
1 | Affinity Capture-MS | [3] | |||
2 | Affinity Capture-Western | [10] | |||
3 | Affinity Capture-Western | [11] | |||
4 | Affinity Capture-Western | [12] | |||
5 | Reconstituted Complex | [13] | |||
6 | Yeast two hybrid | [14] | |||
7 | Yeast two hybrid | [15] | |||
8 | Yeast two hybrid | [16] | |||
Interacting Target Name | CDK inhibitor 4C p18-INK4c (CDKN2C) | Literature-reported Target | Interacting Protein Info | ||
UniProt ID | |||||
Synonyms | P18-INK6; P18-INK4c; P18(INK4c) protein; P18(INK4c); P18 INK4c protein; Cyclin-dependent kinase 6 inhibitor; Cyclin-dependent kinase 4 inhibitor C | ||||
Evidence Score (E-score) | 7 Experimental Evidences | + | |||
1 | Affinity Capture-MS | [2] | |||
2 | Affinity Capture-MS | [3] | |||
3 | Affinity Capture-Western | [17] | |||
4 | Co-crystal Structure | [18] | |||
5 | Fluorescence Resonance Energy Transfer | [7] | |||
6 | Reconstituted Complex | [19] | |||
7 | Yeast two hybrid | [20] | |||
Interacting Protein Name | Cyclin-dependent kinase 4 inhibitor B (CDKN2B) | Interacting Protein | Interacting Protein Info | ||
UniProt ID | |||||
Synonyms | CDK4I; INK4B; MTS2; P15; TP15; p15INK4b | ||||
Evidence Score (E-score) | 6 Experimental Evidences | + | |||
1 | Affinity Capture-MS | [1] | |||
2 | Affinity Capture-MS | [2] | |||
3 | Affinity Capture-MS | [3] | |||
4 | Affinity Capture-Western | [3] | |||
5 | Fluorescence Resonance Energy Transfer | [3] | |||
6 | Yeast two hybrid | [20] | |||
Interacting Protein Name | Cyclin-dependent kinase 4 inhibitor D (CDKN2D) | Interacting Protein | Interacting Protein Info | ||
UniProt ID | |||||
Synonyms | INK4D; p19; p19.INK4D | ||||
Evidence Score (E-score) | 6 Experimental Evidences | + | |||
1 | Affinity Capture-MS | [1] | |||
2 | Affinity Capture-MS | [2] | |||
3 | Affinity Capture-MS | [3] | |||
4 | Co-crystal Structure | [21] | |||
5 | Yeast two hybrid | [20] | |||
6 | Yeast two hybrid | [15] | |||
Interacting Target Name | G1/S-specific cyclin-D1 (CCND1) | Clinical trial Target | Interacting Protein Info | ||
UniProt ID | |||||
Synonyms | PRAD1 oncogene; PRAD1; Cyclin D1; BCL-1 oncogene; BCL-1; BCL1; B-cell lymphoma 1 protein | ||||
Evidence Score (E-score) | 4 Experimental Evidences | + | |||
1 | Affinity Capture-Western | [10] | |||
2 | Affinity Capture-Western | [11] | |||
3 | Co-fractionation | [22] | |||
4 | Reconstituted Complex | [23] | |||
Interacting Protein Name | G1/S-specific cyclin-D2 (CCND2) | Interacting Protein | Interacting Protein Info | ||
UniProt ID | |||||
Synonyms | KIAK0002; MPPH3 | ||||
Evidence Score (E-score) | 4 Experimental Evidences | + | |||
1 | Affinity Capture-MS | [3] | |||
2 | Affinity Capture-Western | [10] | |||
3 | Fluorescence Resonance Energy Transfer | [7] | |||
4 | Yeast two hybrid | [16] | |||
Cell division cycle proteins | [+] 1 Cell division cycle proteins | + | |||
Interacting Protein Name | Retinoblastoma-associated protein (RB1) | Interacting Protein | Interacting Protein Info | ||
UniProt ID | |||||
Synonyms | OSRC; PPP1R130; RB; p105.Rb; pRb; pp110 | ||||
Evidence Score (E-score) | 8 Experimental Evidences | + | |||
1 | Biochemical Activity | [24] | |||
2 | Biochemical Activity | [25] | |||
3 | Biochemical Activity | [26] | |||
4 | Biochemical Activity | [27] | |||
5 | Biochemical Activity | [28] | |||
6 | Biochemical Activity | [29] | |||
7 | Biochemical Activity | [30] | |||
8 | Biochemical Activity | [31] | |||
Kinases | [+] 1 Kinases | + | |||
Interacting Target Name | Cyclin-dependent kinase 2 (CDK2) | Clinical trial Target | Interacting Protein Info | ||
UniProt ID | |||||
Synonyms | SIN3-associated protein; Sin3 associated polypeptide; P33 protein kinase; Cell division protein kinase 2; CDKN2 | ||||
Evidence Score (E-score) | 2 Experimental Evidences | + | |||
1 | Co-localization | [32] | |||
2 | Co-purification | [33] | |||
Other proteins | [+] 2 Other proteins | + | |||
Interacting Target Name | CDK inhibitor 1B p27Kip1 (CDKN1B) | Literature-reported Target | Interacting Protein Info | ||
UniProt ID | |||||
Synonyms | p27Kip1; KIP1; Cyclin-dependent kinase inhibitor p27; Cyclindependent kinase inhibitor p27; Cyclin-dependent kinase inhibitor 1B | ||||
Evidence Score (E-score) | 3 Experimental Evidences | + | |||
1 | Affinity Capture-MS | [1] | |||
2 | Affinity Capture-Western | [34] | |||
3 | Co-localization | [32] | |||
Interacting Target Name | Melanoma differentiation-associated protein 6 (CDKN1A) | Literature-reported Target | Interacting Protein Info | ||
UniProt ID | |||||
Synonyms | WAF1; SDI1; PIC1; P21(WAF1); P21; Melanoma differentiation associated protein 6; MDA-6; MDA6; Cyclin-dependent kinase inhibitor 1; CIP1; CDK-interacting protein 1; CAP20 | ||||
Evidence Score (E-score) | 2 Experimental Evidences | + | |||
1 | Affinity Capture-MS | [1] | |||
2 | Reconstituted Complex | [13] |
References | Top | ||||
---|---|---|---|---|---|
REF 1 | Architecture of the human interactome defines protein communities and disease networks. Nature. 2017 May 25;545(7655):505-509. | ||||
REF 2 | The BioPlex Network: A Systematic Exploration of the Human Interactome. Cell. 2015 Jul 16;162(2):425-440. | ||||
REF 3 | The protein interaction landscape of the human CMGC kinase group. Cell Rep. 2013 Apr 25;3(4):1306-20. | ||||
REF 4 | A CDKN2A mutation in familial melanoma that abrogates binding of p16INK4a to CDK4 but not CDK6. Cancer Res. 2007 Oct 1;67(19):9134-41. | ||||
REF 5 | Hypo-phosphorylation of the retinoblastoma protein (pRb) by cyclin D:Cdk4/6 complexes results in active pRb. Proc Natl Acad Sci U S A. 1997 Sep 30;94(20):10699-704. | ||||
REF 6 | Structural basis for inhibition of the cyclin-dependent kinase Cdk6 by the tumour suppressor p16INK4a. Nature. 1998 Sep 17;395(6699):237-43. | ||||
REF 7 | OncoPPi-informed discovery of mitogen-activated protein kinase kinase 3 as a novel binding partner of c-Myc. Oncogene. 2017 Oct 19;36(42):5852-5860. | ||||
REF 8 | Inhibition of pRb phosphorylation and cell-cycle progression by a 20-residue peptide derived from p16CDKN2/INK4A. Curr Biol. 1996 Jan 1;6(1):84-91. | ||||
REF 9 | CAK-independent activation of CDK6 by a viral cyclin. Mol Biol Cell. 2001 Dec;12(12):3987-99. | ||||
REF 10 | Cdk6-cyclin D3 complex evades inhibition by inhibitor proteins and uniquely controls cell's proliferation competence. Oncogene. 2001 Apr 12;20(16):2000-9. | ||||
REF 11 | Functional characterization of human PFTK1 as a cyclin-dependent kinase. Proc Natl Acad Sci U S A. 2007 May 29;104(22):9248-53. | ||||
REF 12 | Identification of G1 kinase activity for cdk6, a novel cyclin D partner. Mol Cell Biol. 1994 Mar;14(3):2077-86. | ||||
REF 13 | Self-assembling protein microarrays. Science. 2004 Jul 2;305(5680):86-90. | ||||
REF 14 | Next-generation sequencing to generate interactome datasets. Nat Methods. 2011 Jun;8(6):478-80. | ||||
REF 15 | Pooled-matrix protein interaction screens using Barcode Fusion Genetics. Mol Syst Biol. 2016 Apr 22;12(4):863. | ||||
REF 16 | rec-YnH enables simultaneous many-by-many detection of direct protein-protein and protein-RNA interactions. Nat Commun. 2018 Sep 14;9(1):3747. | ||||
REF 17 | Structure-based design of p18INK4c proteins with increased thermodynamic stability and cell cycle inhibitory activity. J Biol Chem. 2002 Dec 13;277(50):48827-33. | ||||
REF 18 | Structural basis of inhibition of CDK-cyclin complexes by INK4 inhibitors. Genes Dev. 2000 Dec 15;14(24):3115-25. | ||||
REF 19 | Growth suppression by p18, a p16INK4/MTS1- and p14INK4B/MTS2-related CDK6 inhibitor, correlates with wild-type pRb function. Genes Dev. 1994 Dec 15;8(24):2939-52. | ||||
REF 20 | A proteome-scale map of the human interactome network. Cell. 2014 Nov 20;159(5):1212-1226. | ||||
REF 21 | Crystal structure of the complex of the cyclin D-dependent kinase Cdk6 bound to the cell-cycle inhibitor p19INK4d. Nature. 1998 Sep 17;395(6699):244-50. | ||||
REF 22 | CDK4 and CDK6 delay senescence by kinase-dependent and p16INK4a-independent mechanisms. Mol Cell Biol. 2007 Jun;27(12):4273-82. | ||||
REF 23 | Regulation of CDK4 activity by a novel CDK4-binding protein, p34(SEI-1). Genes Dev. 1999 Nov 15;13(22):3027-33. | ||||
REF 24 | Biologic and biochemical analyses of p16(INK4a) mutations from primary tumors. J Natl Cancer Inst. 1999 Sep 15;91(18):1569-74. | ||||
REF 25 | PRC1: a human mitotic spindle-associated CDK substrate protein required for cytokinesis. Mol Cell. 1998 Dec;2(6):877-85. | ||||
REF 26 | Direct interaction of p21 cyclin-dependent kinase inhibitor with the retinoblastoma tumor suppressor protein. Biochem Biophys Res Commun. 1999 Sep 16;263(1):35-40. | ||||
REF 27 | Specific regulation of E2F family members by cyclin-dependent kinases. Mol Cell Biol. 1997 Jul;17(7):3867-75. | ||||
REF 28 | Cyclin D3 is down-regulated by rapamycin in HER-2-overexpressing breast cancer cells. Mol Cancer Ther. 2006 Sep;5(9):2172-81. | ||||
REF 29 | Both p16 and p21 families of cyclin-dependent kinase (CDK) inhibitors block the phosphorylation of cyclin-dependent kinases by the CDK-activating kinase. J Biol Chem. 1995 Aug 4;270(31):18195-7. | ||||
REF 30 | p300 is required for orderly G1/S transition in human cancer cells. Oncogene. 2007 Jan 4;26(1):21-9. | ||||
REF 31 | A systematic screen for CDK4/6 substrates links FOXM1 phosphorylation to senescence suppression in cancer cells. Cancer Cell. 2011 Nov 15;20(5):620-34. | ||||
REF 32 | Using an in situ proximity ligation assay to systematically profile endogenous protein-protein interactions in a pathway network. J Proteome Res. 2014 Dec 5;13(12):5339-46. | ||||
REF 33 | Dephosphorylation of human cyclin-dependent kinases by protein phosphatase type 2C alpha and beta 2 isoforms. J Biol Chem. 2000 Nov 3;275(44):34744-9. | ||||
REF 34 | S10 phosphorylation of p27 mediates atRA induced growth arrest in ovarian carcinoma cell lines. J Cell Physiol. 2008 Nov;217(2):558-68. |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.